Physician profile
Shruti A Patel
NPI 1992187082
$47,246.18
in general payments reported to CMS, 2019-2025
43 companies · $384 in 2025
The $384 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,040 · 2020: $1,813 · 2021: $4,431 · 2022: $11K · 2023: $5,806 · 2024: $14K · 2025: $384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,500 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,000 · Travel and Lodging: $2,913 · Food and Beverage: $2,705 · Consulting Fee: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,500.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,000.00 |
| Travel and Lodging | $2,913.05 |
| Food and Beverage | $2,704.88 |
| Consulting Fee | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $22,038.86 | 2019-2024 | Distal Extremities Implants Foot & Ankle Dynanite Staples |
| Supreme Orthopedic Systems, LLC | $6,233.35 | 2020-2025 | |
| Medline Industries LP | $5,000.00 | 2024 | Medline, Medline Unite, Pending |
| Stryker Corporation | $2,981.23 | 2019-2025 | Axs Infinity Ls, Ortholoc 2 Lapifuse |
| Ossio INC | $2,704.23 | 2023-2024 | |
| Linvatec Corporation | $2,500.00 | 2024 | Biobrace 23mm |
| Wright Medical Technology, INC. | $2,154.11 | 2019-2020 | |
| Medical Device Business Services, INC. | $907.08 | 2019 | |
| Melinta Therapeutics, LLC | $312.13 | 2020-2023 | Kimyrsa |
| Horizon Therapeutics Plc | $235.16 | 2020-2022 | |
| Abbott Laboratories | $185.15 | 2024 | Diamondback Peripheral |
| Fortis Surgical, LLC | $171.83 | 2025 | |
| Integra Lifesciences Corporation | $143.04 | 2019-2021 | |
| Embody, INC. | $137.01 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $136.27 | 2020-2021 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shruti Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.